
Bedford, MA based Hologic, Inc. has announced FDA approval of its Selenia Dimensions 3-D system for three dimensional breast imaging.
The system was recommended for approval by the FDA’s Radiological Devices Panel this past September, and is now the first 3D breast imaging solution to be FDA approved. Hologic also announced that existing Dimensions 2-D systems can be upgraded to incorporate the new 3D functionality, which uses multiple X-ray views to produce a 3D representation of the patient’s breast.
From the press release:
Unlike prior-generation mammography systems which generate two-dimensional images, breast tomosynthesis produces three-dimensional images which are intended to reveal the inner architecture of the breast, free from the distortion typically caused by tissue shadowing or density. Tomosynthesis images are acquired with the breast held briefly in compression. The examination, which includes a 3-D tomosynthesis image in combination with a 2-D image, takes only seconds longer than a conventional 2-D digital mammogram at a total exam dose within current FDA guidelines. The 3-D scan results in a stack of thin high-resolution image slices intended to provide clear rendition of structures in the breast and their spatial relationship with the surrounding breast tissue. The images are displayed on a standard diagnostic workstation for review by the radiologist.
Press release: Hologic Receives FDA Approval for First 3-D Digital Mammography (Breast Tomosynthesis) System…
Flashbacks: Hologic 3D Mammography System to be Reviewed by FDA; Hologic’s Selenia Dimensions 3-D Receives Unanimous Recommendation from FDA Advisory Panel





Neuroscientists have long considered extracellular electric fields in the brain to be too weak to affect the day to day functioning of the organ. A new study out of Caltech now shows that in reality these seemingly stray electric fields actually alter the functioning of neurons, giving scientists another puzzle to work out.
New research presented at the American Stroke Association’s International Stroke Conference in Los Angeles shows that robot-assisted therapy is effective in improving arm and shoulder mobility in patients who are paralyzed as a result of a stroke.
Stryker has received clearance from the FDA for its MDM X3 Modular Dual Mobility Mobile Bearing Hip System.


Remember the good old days when primary hyperhidrosis of the upper limbs was treated by sympathectomy via thoracotomy? As time goes by, we have new kids on the block, and they have zero respect for traditions. Miramar Labs from Sunnyvale, CA has announced 510(k) clearance of its miraDry System for treatment of excessive underarm sweat. The system utilizes microwave energy to cause thermal necrosis of sweat glands in the target area. Treatment with the miraDry system is noninvasive and requires two hour-long doctor’s office visits.
From the product page:




